Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma

Documenti analoghi

• Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic Chemotherapy
  di: Tomoyuki Satake, et al.
  Pubblicazione: (2024)
• Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first‐in‐human phase I study
  di: Chigusa Morizane, et al.
  Pubblicazione: (2024)
• Electronic Patient‐Reported Outcome Quality of Life Score in Japanese Patients With Pancreatic Cancer on Second‐Line Chemotherapy: A Multicenter Observational Study
  di: Yuki Takumoto, et al.
  Pubblicazione: (2025)
• Statistics of Visceral Sarcoma in Japan: Report From the Population‐Based National Cancer Registry (NCR) in Japan
  di: Shudai Muramatsu, et al.
  Pubblicazione: (2024)
• Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population‐Based Cancer Registry in Japan 2016–2019
  di: Toshiyuki Takemori, et al.
  Pubblicazione: (2025)